Q: Cipher, is hosting an investor webcast today, I am hoping you can report and summarize this event. The question for me regarding this co. is are they growing and I am looking for proof of traction not only in revs but also profits.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Cantor just initiated coverage with a $27 price target on Therapeutics MD saying their three products are under-appreciated and sales will rise faster than expected.
What do you think and is there a short position on this stock?
Thanks.
What do you think and is there a short position on this stock?
Thanks.
Q: why the sudden drop today td had nothing to indicate anything that would warrant a10 percent drop thanks as always
Q: Hi
I have not had time to do the research lately, but what is happening to SIS. I bought it at $16.60 abut a month ago when it was showing good potential and growth. I know that the stock market is turbulent right now, and affecting good companies negatively, but did I miss something important about this company. I bought 300 shares, should I hold on to them or is there something tragic looming on the horizon for SIS.
I have not had time to do the research lately, but what is happening to SIS. I bought it at $16.60 abut a month ago when it was showing good potential and growth. I know that the stock market is turbulent right now, and affecting good companies negatively, but did I miss something important about this company. I bought 300 shares, should I hold on to them or is there something tragic looming on the horizon for SIS.
Q: Morning fellas:
Steven t from Lester who I believe is one of the better stock pickers on BNN including yourselves had this name as a top pick . I know in the past you guys were not as keen. Do u agree with mr t on his assessment and is it a buying oppurtunity.
Thanks
Mark.
Steven t from Lester who I believe is one of the better stock pickers on BNN including yourselves had this name as a top pick . I know in the past you guys were not as keen. Do u agree with mr t on his assessment and is it a buying oppurtunity.
Thanks
Mark.
Q: Would you please give your opinion on these healthcare equities.
Q: Of these two healthcare companies, which do you prefer? WCG dropped a lot in the recent sell off whereas CNC did not? I do own UNH but I'm looking for another for a long term hold?
-
Bausch Health Companies Inc. (BHC $11.03)
-
CRH Medical Corporation (CRH $4.99)
-
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA $32.51)
Q: I am aware that these companies have high debt levels. However, would you view any one of them investable? Or would there be similar companies with better growth prospects?
Thanks for your input!
Thanks for your input!
Q: Aside from JNJ, my US portfolio has no healthcare/biotech stocks. How would you assess these two companies?
Thank you, Team!
P.S. The BNN presentation was very informative!
Thank you, Team!
P.S. The BNN presentation was very informative!
Q: Hello Peter,
With the cannabis stocks trading 50% below the legalization date, I would have thought any big companies that wanted to take an equity position in cannabis companies like Canntrust , Aphria, etc would have done it by now. Any thoughts on this? Also, I am starting to wonder if Knight is worth letting go now. This looks like a 30 year timeframe stock the way it is going... Appreciate the comments
With the cannabis stocks trading 50% below the legalization date, I would have thought any big companies that wanted to take an equity position in cannabis companies like Canntrust , Aphria, etc would have done it by now. Any thoughts on this? Also, I am starting to wonder if Knight is worth letting go now. This looks like a 30 year timeframe stock the way it is going... Appreciate the comments
Q: What are your thoughts on CRH at this time. It has moved up in the last few days. Is it too rich? What do you think of it's turn around? Do you think it has a chance to reach $6+? Would any of you buy into this or is just "OK"?
Thanks for your help,
Stephen
Thanks for your help,
Stephen
Q: My biggest position is in Knight and my two biggest concerns are the possibility that Mr. Goodman's health is deteriorating following his accident which could affect his zeal for a large deal and, second, if his reputation as a bargain-hunter is precluding him from having access to good deals as sellers may only view him as a desperate last resort.
Finally, the trading in this stock seems consumed by day traders generating a flurry of orders following the limited buy/sell from real investors. Is someone propping this stock up to generate action while the shareholder base yawns through the daily action waiting with exasperation for the company to put their $800M to WORK!!
Thank you.
Finally, the trading in this stock seems consumed by day traders generating a flurry of orders following the limited buy/sell from real investors. Is someone propping this stock up to generate action while the shareholder base yawns through the daily action waiting with exasperation for the company to put their $800M to WORK!!
Thank you.
Q: I was wondering your opinion about Cypher Pharmaceuticals and Centric Health Care. Would you buy either of these and could you give an explanation, thanks
Mary
Mary
Q: ILUVIEN approval for GUD. How big a deal is this. I noticed on the Globe and Mail GUD was proposed as a small cap to watch. I don<t know how important this deal is. But, i see it didn<t affect the stock price much.
thanks for the great service
thanks for the great service
Q: ..how do you view Antibe's latest results? thanks.
Q: What are your thoughts on AMRN? Would you recommend buying at this time?
Q: Thank you again for this excellent service. I have a question about Savaria. In their most recent quarterly results, for the 9 months ended September 2018, stock-based compensation is $899K on $12.9M income. If I have done my calculation correctly, the stock-based compensation is about 7% of expenses. I do not know how to find the base salaries for the management (which would presumably further increase the management cost for the firm).
Is this not a lot excessive? Should I be concerned about the "cost" of management and how this cost could dilute shares or profits?
Thank-you
Is this not a lot excessive? Should I be concerned about the "cost" of management and how this cost could dilute shares or profits?
Thank-you
Q: Any idea why the big drop in Biosyent this week. Also thoughts on their Q3 results
Thanks
Don
Thanks
Don
Q: I Have held Knight Therapeutics (GUD.TO) in my Granddaughter's trust account for a number of years, but sold today with the jump in price for a small profit. I'M am now looking for a stock in the Health Care sector to replace it, preferably one that pays a dividend.
Would you be comfortable with Savaria (SIS.TO) for a 3-4 year hold? Could you recommend one or two others? Many thanks
Would you be comfortable with Savaria (SIS.TO) for a 3-4 year hold? Could you recommend one or two others? Many thanks
Q: You wonder how many people would actually be up on this name as many got shares from the spin off from PHM which they could be down on as I am.